EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bisphosphonates synergistically enhance the antifungal activity of azoles in dermatophytes and other pathogenic molds

Aidan Kane iD, Joanna G Rothwell, Annabel Guttentag, Steven Hainsworth, Dee Carter iD

mSphere · 25.06.2024 · 9 (6)

DOI: 10.1128/msphere.00248-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mSphere, erschienen am 25.06.2024. Verfasst von Aidan Kane und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Life and Environmental Sciences, The University of Sydney, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Diphosphonates, Azoles, Antifungal Agents, Arthrodermataceae. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Sydney MBI Seed Funding Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Superficial infections of the skin, hair, and nails by fungal dermatophytes are the most prevalent of human mycoses, and many infections are refractory to treatment. As current treatment options are limited, recent research has explored drug synergy with azoles for dermatophytoses. Bisphosphonates, which are approved to treat osteoporosis, can synergistically enhance the activity of azoles in diverse yeast pathogens but their activity has not been explored in dermatophytes or other molds. Market bisphosphonates risedronate, alendronate, and zoledronate (ZOL) were evaluated for antifungal efficacy and synergy with three azole antifungals: fluconazole (FLC), itraconazole (ITR), and ketoconazole (KET). ZOL was the most active bisphosphonate tested, displaying moderate activity against nine dermatophyte species (MIC range 64–256 µg/mL), and was synergistic with KET in eight of these species. ZOL was also able to synergistically improve the anti-biofilm activity of KET and combining KET and ZOL prevented the development of antifungal resistance. Rescue assays in Trichophyton rubrum revealed that the inhibitory effects of ZOL alone and in combination with KET were due to the inhibition of squalene synthesis. Fluorescence microscopy using membrane- and ROS-sensitive probes demonstrated that ZOL and KET:ZOL compromised membrane structure and induced oxidative stress. Antifungal activity and synergy between bisphosphonates and azoles were also observed in other clinically relevant molds, including species of Aspergillus and Mucor . These findings indicate that repurposing bisphosphonates as antifungals is a promising strategy for revitalising certain azoles as topical antifungals, and that this combination could be fast-tracked for investigation in clinical trials. IMPORTANCE Fungal infections of the skin, hair, and nails, generally grouped together as “tineas” are the most prevalent infectious diseases globally. These infections, caused by fungal species known as dermatophytes, are generally superficial, but can in some cases become aggressive. They are also notoriously difficult to resolve, with few effective treatments and rising levels of drug resistance. Here, we report a potential new treatment that combines azole antifungals with bisphosphonates. Bisphosphonates are approved for the treatment of low bone density diseases, and in fungi they inhibit the biosynthesis of the cell membrane, which is also the target of azoles. Combinations were synergistic across the dermatophyte species and prevented the development of resistance. We extended the study to molds that cause invasive disease, finding synergy in some problematic species. We suggest bisphosphonates could be repurposed as synergents for tinea treatment, and that this combination could be fast-tracked for use in clinical therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DiphosphonatesAzolesAntifungal AgentsArthrodermataceaeDrug SynergismHumansZoledronic AcidMycosesBiofilmsKetoconazoleDrug Resistance, FungalSqualeneHyphaeOxidative Stress

Stichwörter der Autor:innen

Trichophytonantifungal agentsantifungal therapyazolebisphosphonatedermatophytesdrug synergyketoconazolezolendronate

Substanzen

DiphosphonatesAzolesAntifungal AgentsZoledronic AcidKetoconazoleSqualene

Autor:innen und Institutionen

  • School of Life and Environmental Sciences, The University of Sydney, Sydney, New South Wales, Australia.
  • School of Science, Royal Melbourne Institute of Technology, Melbourne, Victoria, Australia.
  • Sydney Institute for Infectious Diseases, University of Sydney, Sydney, New South Wales, Australia.

ORCID-Profile: Aidan Kane, Dee Carter

Förderung

  • University of Sydney MBI Seed Funding Grant

Zitieren

APA

Kane, A., Rothwell, J. G., Guttentag, A., Hainsworth, S., & Carter, D. (2024). Bisphosphonates synergistically enhance the antifungal activity of azoles in dermatophytes and other pathogenic molds. mSphere, 9(6). https://doi.org/10.1128/msphere.00248-24

Vancouver

Kane A, Rothwell JG, Guttentag A, Hainsworth S, Carter D. Bisphosphonates synergistically enhance the antifungal activity of azoles in dermatophytes and other pathogenic molds. mSphere. 2024;9(6). doi:10.1128/msphere.00248-24

BibTeX
@article{Kane2024,
  author = {Kane, Aidan and Rothwell, Joanna G and Guttentag, Annabel and Hainsworth, Steven and Carter, Dee},
  title = {Bisphosphonates synergistically enhance the antifungal activity of azoles in dermatophytes and other pathogenic molds},
  journal = {mSphere},
  year = {2024},
  volume = {9},
  number = {6},
  doi = {10.1128/msphere.00248-24}
}
Kostenlos starten →